# PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

> **NCT03660345** · PHASE3 · COMPLETED · sponsor: **Rush Eye Associates** · enrollment: 11 (actual)

## Conditions studied

- Diabetic Retinopathy
- Macular Edema

## Interventions

- **PROCEDURE:** PPV/MP
- **DRUG:** Intravitreal injection

## Key facts

- **NCT ID:** NCT03660345
- **Lead sponsor:** Rush Eye Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-04
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660345, "PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03660345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*